We've updated our Privacy Policy. Questions? Email us any time at privacy@ground.newsWe've updated our Privacy Policy with additional info on research surveys, our browser extension, cookie management, and ad performance measurement. Questions? Email us any time at privacy@ground.news
Read the full article on stephaneLarue.com A study published in JAMA Network Open, involving more than 133,000 diabetic patients, shows that GLP-1 drugs such as Ozempic reduce the risk of fracture, regardless of weight loss.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Read the full article on stephaneLarue.com A study published in JAMA Network Open, involving more than 133,000 diabetic patients, shows that GLP-1 drugs such as Ozempic reduce the risk of fracture, regardless of weight loss.